Abstract
Successful use of fluorescence polarization assays (FPAs) in human clinical, infectious disease, and drug discovery fields has prompted us to extend its use to the grain mycotoxin field. An antibody specific to a mycotoxin and a mycotoxin-fluorophore conjugate are developed. Free toxin (extracted from the grains with a suitable solvent) competes with the toxin-fluorophore conjugate for the antibody and a change in FP relative to the quantity of free toxin occurs. This change is compared to a standard curve obtained by using known quantities of toxin. The use of FP and toxin-fluorophore conjugates for the quantification of fumonisins, deoxynivalenol and aflatoxins is described. These assays are field portable, simple to perform, rapid and require no washing steps.
Keywords: Fluorescence Polarization, Mycotoxins, deoxynivalenol, aflatoxins, Vomitoxin
Combinatorial Chemistry & High Throughput Screening
Title: Fluorescence Polarization (FP) Assays for the Determination of Grain Mycotoxins (Fumonisins, DON Vomitoxin and Aflatoxins)
Volume: 6 Issue: 3
Author(s): Mohammad S. Nasir and Michael E. Jolley
Affiliation:
Keywords: Fluorescence Polarization, Mycotoxins, deoxynivalenol, aflatoxins, Vomitoxin
Abstract: Successful use of fluorescence polarization assays (FPAs) in human clinical, infectious disease, and drug discovery fields has prompted us to extend its use to the grain mycotoxin field. An antibody specific to a mycotoxin and a mycotoxin-fluorophore conjugate are developed. Free toxin (extracted from the grains with a suitable solvent) competes with the toxin-fluorophore conjugate for the antibody and a change in FP relative to the quantity of free toxin occurs. This change is compared to a standard curve obtained by using known quantities of toxin. The use of FP and toxin-fluorophore conjugates for the quantification of fumonisins, deoxynivalenol and aflatoxins is described. These assays are field portable, simple to perform, rapid and require no washing steps.
Export Options
About this article
Cite this article as:
Nasir S. Mohammad and Jolley E. Michael, Fluorescence Polarization (FP) Assays for the Determination of Grain Mycotoxins (Fumonisins, DON Vomitoxin and Aflatoxins), Combinatorial Chemistry & High Throughput Screening 2003; 6 (3) . https://dx.doi.org/10.2174/138620703106298310
DOI https://dx.doi.org/10.2174/138620703106298310 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry An Experimental and Theoretical Approach to Understand Fever, DENF & its Cure
Infectious Disorders - Drug Targets The Isoprostanes - Unique Products of Arachidonate Peroxidation: Their Role as Mediators of Oxidant Stress
Current Pharmaceutical Design Environmental Factors and Hypertension
Current Pharmaceutical Design The Inhibitory Effects of Some Artificial Food Colorings on α-amylase and α-glucosidase: In vitro and In silico Studies
Current Enzyme Inhibition Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent
Anti-Cancer Agents in Medicinal Chemistry Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An <i>In-Silico</i> Approach
Current Drug Research Reviews Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry Safety and Quality of Nutraceuticals: Have FSSAI Guidelines been Able to Blaze the Trail?
Applied Clinical Research, Clinical Trials and Regulatory Affairs Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology: From Irritable Bowel Syndrome to Colorectal Cancer
Current Drug Targets Application of Affinity Selection-Mass Spectrometry Assays to Purification and Affinity-Based Screening of the Chemokine Receptor CXCR4
Combinatorial Chemistry & High Throughput Screening Prodrug Strategy for Enhancing Drug Delivery via Skin
Current Drug Discovery Technologies Metabotyping of a Protected Non-Model Organism, Green Sea Turtle (Chelonia mydas), using <sup>1</sup>H NMR Spectroscopy and Optimized Plasma Methods for Metabolomics
Current Metabolomics Exosomal MicroRNAs in Tumoral U87 MG Versus Normal Astrocyte Cells
MicroRNA Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
Current Pharmaceutical Design Assessment of a Novel Vitamin D<sub>3</sub> Formulation with Nanostructured Lipid Carriers for Transdermal Delivery
Current Drug Delivery Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design Tool Developments for Structure-Function Studies of Host Defense Peptides
Protein & Peptide Letters A Neural Network-Based QSAR Approach for Exploration of Diverse Multi-Tyrosine Kinase Inhibitors and its Comparison with a Fragment- Based Approach
Current Computer-Aided Drug Design